Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$165.87 - $220.95 $33,174 - $44,190
-200 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$180.37 - $226.26 $34,270 - $42,989
190 Added 1900.0%
200 $39,000
Q4 2020

Feb 03, 2021

SELL
$148.08 - $206.57 $1,184 - $1,652
-8 Reduced 44.44%
10 $2,000
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $471 - $702
-5 Reduced 21.74%
18 $2,000
Q1 2020

May 14, 2020

BUY
$84.96 - $109.14 $509 - $654
6 Added 35.29%
23 $2,000
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $76 - $95
-1 Reduced 5.56%
17 $1,000
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $975 - $1,547
18 New
18 $2,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.67B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.